• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

pfe

  1. Vyleesi and Pfizer a good fit?

    With Viagra patents expired does it make sense for Pfizer to buy Vyleesi rights?
  2. Pfizer reports fourth quarter results

    Pfizer (PFE) reported a better-than-expected 2% increase in fourth-quarter revenues to $13.9 billion. Earnings rose to 64 cents per share from 62 cents per share a year ago, surpassing analysts’ estimate of 63 cents per share. PFE shares were down 3% during pre-market trading on Tuesday. Shares...